The paradox of implantable cardioverter-defibrillator: When guidelines may play against care improvement

Affiliations

¹ Healthcare Research and Innovation Program, IRCS-HTA, Bruno Kessler Foundation, Trento, Italy; Department of Cardiology, Santa Chiara Hospital, Trento, Italy. Electronic address: disertorim@gmail.com.
² Healthcare Research and Innovation Program, IRCS-HTA, Bruno Kessler Foundation, Trento, Italy; Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy; Department of Physics, University of Trento, Trento, Italy.
³ Department of Industrial Engineering, University of Trento, Trento, Italy; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
⁴ Department of Physics, University of Trento, Trento, Italy.
⁵ Healthcare Research and Innovation Program, IRCS-HTA, Bruno Kessler Foundation, Trento, Italy; Department of Industrial Engineering, University of Trento, Trento, Italy.

Comment

Marcello Disertori et al. Am Heart J. 2021 Mar.

. 2021 Mar:233:149-150.

doi: 10.1016/j.ahj.2020.11.012.

¹ Healthcare Research and Innovation Program, IRCS-HTA, Bruno Kessler Foundation, Trento, Italy; Department of Cardiology, Santa Chiara Hospital, Trento, Italy. Electronic address: disertorim@gmail.com.
² Healthcare Research and Innovation Program, IRCS-HTA, Bruno Kessler Foundation, Trento, Italy; Institute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy; Department of Physics, University of Trento, Trento, Italy.
³ Department of Industrial Engineering, University of Trento, Trento, Italy; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
⁴ Department of Physics, University of Trento, Trento, Italy.
⁵ Healthcare Research and Innovation Program, IRCS-HTA, Bruno Kessler Foundation, Trento, Italy; Department of Industrial Engineering, University of Trento, Trento, Italy.

No abstract available

Comment in

Response to: The paradox of implantable cardioverter-defibrillator: When guidelines play against care improvement.
Chery GS, Kamp N, Kosinski AS, Schmidler GS, Lopes RD, Patel M, Al-Khatib SM. Chery GS, et al. Am Heart J. 2021 Mar;233:151-152. doi: 10.1016/j.ahj.2020.11.014. Am Heart J. 2021. PMID: 33610195 No abstract available.

Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review.
Chery G, Kamp N, Kosinski AS, Schmidler GS, Lopes RD, Patel M, Al-Khatib SM. Chery G, et al. Am Heart J. 2020 Nov;229:52-60. doi: 10.1016/j.ahj.2020.08.004. Epub 2020 Aug 11. Am Heart J. 2020. PMID: 32916608 Free PMC article.